Insights Widest with the analysis, Proactive gives perspectives that others don't.

Shield Therapeutics PLC - Shield Therapeutics' new findings support negotiations with prospective US partners, says Peel Hunt Shield Therapeutics supported in negotiations with prospective US partners by new findings, says Peel Hunt

Analysts say completing the negotiations represents significant further upside potential for the...

2 days, 8 hours ago
Deep dive

e-Therapeutics' new boss sees lots of potential

Danish giant Novo Nordisk recently signed up to use its NDD platform, and bosses expect more...

2 days, 10 hours ago
Deep dive

Shield Therapeutics encouraged by US interest in iron deficiency treatment

Below we take a closer look at Shield Therapeutics...

2 days, 10 hours ago

Demand for healthcare stocks similar to late 90s tech boom, says analyst

Turner Pope's Andy Thacker said there has been a boom in investor demand for firms in the...

3 days, 9 hours ago
Deep dive

Tiziana Life Sciences upbeat on potential for coronavirus treatment

TZLS-501 is a class of monoclonal antibody (mAb) called an anti-interleukin-6 receptor, or...

4 days, 7 hours ago


OKYO Pharma Limited appoints top Beverly Hills surgeon to lead its...

Dr James Khodabakhsh MD speaks to Proactive's Andrew Scott following his appointment as chair of OKYO Pharma Limited's (LON:OKYO) Scientific Advisory Board. He'll be tasked with bringing together a small group of leaders to review and inform the company's plans to progress its lead product...

2 days, 13 hours ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.